Active, not recruiting
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
NCT06590857
- Conditions
- Advanced Breast Cancer, Bone Metastases in Subjects With Advanced Breast Cancer, Breast Diseases, +13 more
- Locations
-
- Research Facility Phoenix, Arizona, United States
- Research Facility Irvine, California, United States
- Research Facility San Diego, California, United States
- Research Facility Santa Monica, California, United States